313 related articles for article (PubMed ID: 28500393)
1. Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.
Snowhite IV; Allende G; Sosenko J; Pastori RL; Messinger Cayetano S; Pugliese A
Diabetologia; 2017 Aug; 60(8):1409-1422. PubMed ID: 28500393
[TBL] [Abstract][Full Text] [Related]
2. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA;
Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199
[TBL] [Abstract][Full Text] [Related]
3. Increased Expression of Circulating microRNA 101-3p in Type 1 Diabetes Patients: New Insights Into miRNA-Regulated Pathophysiological Pathways for Type 1 Diabetes.
Santos AS; Cunha Neto E; Fukui RT; Ferreira LRP; Silva MER
Front Immunol; 2019; 10():1637. PubMed ID: 31396209
[TBL] [Abstract][Full Text] [Related]
4. Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk.
Tosur M; Geyer SM; Rodriguez H; Libman I; Baidal DA; Redondo MJ;
Diabetologia; 2018 Sep; 61(9):2043-2053. PubMed ID: 29931415
[TBL] [Abstract][Full Text] [Related]
5. Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes.
Åkerman L; Casas R; Ludvigsson J; Tavira B; Skoglund C
PLoS One; 2018; 13(1):e0191067. PubMed ID: 29346396
[TBL] [Abstract][Full Text] [Related]
6. The implications of autoantibodies to a single islet antigen in relatives with normal glucose tolerance: development of other autoantibodies and progression to type 1 diabetes.
Bingley PJ; Boulware DC; Krischer JP;
Diabetologia; 2016 Mar; 59(3):542-9. PubMed ID: 26676824
[TBL] [Abstract][Full Text] [Related]
7. Extended family history of type 1 diabetes in HLA-predisposed children with and without islet autoantibodies.
Kuusela S; Keskinen P; Pokka T; Knip M; Ilonen J; Vähäsalo P; Veijola R
Pediatr Diabetes; 2020 Dec; 21(8):1447-1456. PubMed ID: 32939969
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemic clamp and oral glucose tolerance test for 3-year prediction of clinical onset in persistently autoantibody-positive offspring and siblings of type 1 diabetic patients.
Balti EV; Vandemeulebroucke E; Weets I; Van De Velde U; Van Dalem A; Demeester S; Verhaeghen K; Gillard P; De Block C; Ruige J; Keymeulen B; Pipeleers DG; Decochez K; Gorus FK;
J Clin Endocrinol Metab; 2015 Feb; 100(2):551-60. PubMed ID: 25405499
[TBL] [Abstract][Full Text] [Related]
9. A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion.
Bonifacio E; Krumsiek J; Winkler C; Theis FJ; Ziegler AG
Acta Diabetol; 2014; 51(3):403-11. PubMed ID: 24249616
[TBL] [Abstract][Full Text] [Related]
10. Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY).
Frohnert BI; Ide L; Dong F; Barón AE; Steck AK; Norris JM; Rewers MJ
Diabetologia; 2017 Jun; 60(6):998-1006. PubMed ID: 28314946
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
[TBL] [Abstract][Full Text] [Related]
12. Increasing ICA512 autoantibody titers predict development of abnormal oral glucose tolerance tests.
Sanda S;
Pediatr Diabetes; 2018 Mar; 19(2):271-276. PubMed ID: 28707353
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid status in infancy is associated with the risk of type 1 diabetes-associated autoimmunity.
Niinistö S; Takkinen HM; Erlund I; Ahonen S; Toppari J; Ilonen J; Veijola R; Knip M; Vaarala O; Virtanen SM
Diabetologia; 2017 Jul; 60(7):1223-1233. PubMed ID: 28474159
[TBL] [Abstract][Full Text] [Related]
14. Influenza A virus antibodies show no association with pancreatic islet autoantibodies in children genetically predisposed to type 1 diabetes.
Kondrashova A; Nurminen N; Patrikainen M; Huhtala H; Lehtonen J; Toppari J; Ilonen J; Simell OG; Veijola R; Knip M; Hyöty H
Diabetologia; 2015 Nov; 58(11):2592-5. PubMed ID: 26253765
[TBL] [Abstract][Full Text] [Related]
15. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
Endesfelder D; Hagen M; Winkler C; Haupt F; Zillmer S; Knopff A; Bonifacio E; Ziegler AG; Zu Castell W; Achenbach P
Diabetologia; 2016 Oct; 59(10):2172-80. PubMed ID: 27400691
[TBL] [Abstract][Full Text] [Related]
16. Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes.
Pflueger M; Seppänen-Laakso T; Suortti T; Hyötyläinen T; Achenbach P; Bonifacio E; Orešič M; Ziegler AG
Diabetes; 2011 Nov; 60(11):2740-7. PubMed ID: 22025777
[TBL] [Abstract][Full Text] [Related]
17. Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives.
Achenbach P; Warncke K; Reiter J; Williams AJ; Ziegler AG; Bingley PJ; Bonifacio E
Diabetologia; 2006 Dec; 49(12):2969-76. PubMed ID: 17019596
[TBL] [Abstract][Full Text] [Related]
18. Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents.
Ferrara-Cook C; Geyer SM; Evans-Molina C; Libman IM; Becker DJ; Gitelman SE; Redondo MJ;
Diabetes Care; 2020 Mar; 43(3):580-587. PubMed ID: 31937610
[TBL] [Abstract][Full Text] [Related]
19. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance.
Redondo MJ; Sosenko J; Libman I; McVean JJF; Tosur M; Atkinson MA; Becker D; Geyer S
J Clin Endocrinol Metab; 2020 May; 105(5):1629-40. PubMed ID: 31867614
[TBL] [Abstract][Full Text] [Related]
20. Peptide serum markers in islet autoantibody-positive children.
von Toerne C; Laimighofer M; Achenbach P; Beyerlein A; de Las Heras Gala T; Krumsiek J; Theis FJ; Ziegler AG; Hauck SM
Diabetologia; 2017 Feb; 60(2):287-295. PubMed ID: 27815605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
